• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒核衣壳蛋白的质谱分析揭示了伪装聚糖和独特的翻译后修饰

Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications.

作者信息

Sun Zeyu, Zheng Xiaoqin, Ji Feiyang, Zhou Menghao, Su Xiaoling, Ren Keyi, Li Lanjuan

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

出版信息

Infect Microbes Dis. 2021 Aug 3;3(3):149-157. doi: 10.1097/IM9.0000000000000071. eCollection 2021 Sep.

DOI:10.1097/IM9.0000000000000071
PMID:38630108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8454284/
Abstract

The devastating coronavirus disease 2019 (COVID-19) pandemic has prompted worldwide efforts to study structural biological traits of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its viral components. Compared to the Spike protein, which is the primary target for currently available vaccines or antibodies, knowledge about other virion structural components is incomplete. Using high-resolution mass spectrometry, we report a comprehensive post-translational modification (PTM) analysis of nucleocapsid phosphoprotein (NCP), the most abundant structural component of the SARS-CoV-2 virion. In addition to phosphoryl groups, we show that the SARS-CoV-2 NCP is decorated with a variety of PTMs, including -glycans and ubiquitin. Based on newly identified PTMs, refined protein structural models of SARS-CoV-2 NCP were proposed and potential immune recognition epitopes of NCP were aligned with PTMs. These data can facilitate the design of novel vaccines or therapeutics targeting NCP, as valuable alternatives to the current vaccination and treatment paradigm that is under threat of the ever-mutating SARS-CoV-2 Spike protein.

摘要

2019年冠状病毒病(COVID-19)大流行促使全球致力于研究严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其病毒成分的结构生物学特性。与作为当前可用疫苗或抗体主要靶点的刺突蛋白相比,关于病毒体其他结构成分的了解尚不完整。我们使用高分辨率质谱法,报告了对核衣壳磷蛋白(NCP)的全面翻译后修饰(PTM)分析,NCP是SARS-CoV-2病毒体中最丰富的结构成分。除了磷酸基团外,我们还表明SARS-CoV-2 NCP带有多种PTM,包括聚糖和泛素。基于新鉴定的PTM,提出了SARS-CoV-2 NCP的精细蛋白质结构模型,并将NCP潜在的免疫识别表位与PTM进行了比对。这些数据有助于设计针对NCP的新型疫苗或疗法,作为当前疫苗接种和治疗模式的有价值替代方案,而当前模式正受到不断变异的SARS-CoV-2刺突蛋白的威胁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/269b948c0480/im9-3-149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/a408c81228a1/im9-3-149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/8948c02c1a78/im9-3-149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/269b948c0480/im9-3-149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/a408c81228a1/im9-3-149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/8948c02c1a78/im9-3-149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705f/8454284/269b948c0480/im9-3-149-g003.jpg

相似文献

1
Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications.新型冠状病毒核衣壳蛋白的质谱分析揭示了伪装聚糖和独特的翻译后修饰
Infect Microbes Dis. 2021 Aug 3;3(3):149-157. doi: 10.1097/IM9.0000000000000071. eCollection 2021 Sep.
2
Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.新型冠状病毒HCoV-19刺突蛋白与人血管紧张素转换酶2的质谱分析揭示了伪装聚糖和独特的翻译后修饰。
Engineering (Beijing). 2021 Oct;7(10):1441-1451. doi: 10.1016/j.eng.2020.07.014. Epub 2020 Aug 30.
3
Protein post-translational modification in SARS-CoV-2 and host interaction.SARS-CoV-2 与宿主相互作用中的蛋白质翻译后修饰。
Front Immunol. 2023 Jan 13;13:1068449. doi: 10.3389/fimmu.2022.1068449. eCollection 2022.
4
Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein.严重急性呼吸综合征冠状病毒 2 核衣壳蛋白的可变翻译后修饰。
Glycobiology. 2021 Sep 20;31(9):1080-1092. doi: 10.1093/glycob/cwab044.
5
Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.采用同位素稀释串联质谱法对 SARS-CoV-2 刺突蛋白和核衣壳蛋白进行定量分析。
Vaccine. 2021 Aug 23;39(36):5106-5115. doi: 10.1016/j.vaccine.2021.07.066. Epub 2021 Jul 24.
6
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.采用微阵列和其他 12 种免疫分析法评估急性 SARS-CoV-2 感染中 S1、S2 和 NCP 特异性 IgM、IgA 和 IgG 抗体的动力学。
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02890-20.
7
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.针对病毒内部保守核衣壳 (N) 蛋白作为 SARS-CoV 新型疫苗。
Biosci Rep. 2021 Sep 30;41(9). doi: 10.1042/BSR20211491.
8
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.基于 SARS-CoV 免疫学研究的 COVID-19 冠状病毒(SARS-CoV-2)潜在疫苗靶点的初步鉴定。
Viruses. 2020 Feb 25;12(3):254. doi: 10.3390/v12030254.
9
SARS-CoV-2 Spike Protein Post-Translational Modification Landscape and Its Impact on Protein Structure and Function via Computational Prediction.严重急性呼吸综合征冠状病毒2刺突蛋白的翻译后修饰图谱及其通过计算预测对蛋白质结构和功能的影响
Research (Wash D C). 2023 Mar 8;6:0078. doi: 10.34133/research.0078.
10
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.市售 SARS-CoV-2 IgG ELISA 在非洲来源血清样本中的特异性有限。
Trop Med Int Health. 2021 Jun;26(6):621-631. doi: 10.1111/tmi.13569. Epub 2021 Apr 5.

引用本文的文献

1
SARS-CoV-2 Assembly: Gaining Infectivity and Beyond.SARS-CoV-2 组装:获得感染性及其他。
Viruses. 2024 Oct 22;16(11):1648. doi: 10.3390/v16111648.
2
Water-glycan interactions drive the SARS-CoV-2 spike dynamics: insights into glycan-gate control and camouflage mechanisms.水-聚糖相互作用驱动新冠病毒刺突蛋白动态变化:对聚糖门控和伪装机制的见解
Chem Sci. 2024 Aug 23;15(35):14177-87. doi: 10.1039/d4sc04364b.
3
Phase Separation of SARS-CoV-2 Nucleocapsid Protein with TDP-43 Is Dependent on C-Terminus Domains.SARS-CoV-2 核衣壳蛋白与 TDP-43 的液-液相分离依赖于 C 端结构域。

本文引用的文献

1
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.SARS-CoV-2 刺突糖蛋白的反复缺失可导致抗体逃逸。
Science. 2021 Mar 12;371(6534):1139-1142. doi: 10.1126/science.abf6950. Epub 2021 Feb 3.
2
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.预测用于治疗 COVID-19 的抗体所识别的病毒突变逃逸情况。
Science. 2021 Feb 19;371(6531):850-854. doi: 10.1126/science.abf9302. Epub 2021 Jan 25.
3
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Int J Mol Sci. 2024 Aug 12;25(16):8779. doi: 10.3390/ijms25168779.
4
Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein.重新探讨补体凝集素途径蛋白酶 MASP-2 与 SARS-CoV-2 核衣壳蛋白之间的相互作用。
Front Immunol. 2024 Jun 7;15:1419165. doi: 10.3389/fimmu.2024.1419165. eCollection 2024.
5
Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.用于验证病毒质量保证面板的 SARS-CoV-2 核衣壳蛋白抗原检测试剂的设计与开发。
Viruses. 2024 Apr 24;16(5):662. doi: 10.3390/v16050662.
6
Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study.悬浮培养的HEK-293细胞中的瞬时表达作为一种快速且强大的工具:以SARS-CoV-2 N蛋白和嵌合SARS-CoV-2 N-CD154蛋白为例进行研究
Biomedicines. 2023 Nov 14;11(11):3050. doi: 10.3390/biomedicines11113050.
7
Delineating Conformational Variability in Small Protein Structures Using Combinatorial Refinement Strategies.使用组合优化策略描绘小蛋白质结构中的构象变异性
Micromachines (Basel). 2023 Sep 29;14(10):1869. doi: 10.3390/mi14101869.
8
Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.基于蛋白质组学的 SARS-CoV-2 感染人鼻咽样本的质谱分析。
Mass Spectrom Rev. 2024 Jan-Feb;43(1):193-229. doi: 10.1002/mas.21813. Epub 2022 Sep 29.
9
Evaluation of Variant-Specific Peptides for Detection of SARS-CoV-2 Variants of Concern.评估用于检测关注的 SARS-CoV-2 变体的变异特异性肽。
J Proteome Res. 2022 Oct 7;21(10):2443-2452. doi: 10.1021/acs.jproteome.2c00325. Epub 2022 Sep 15.
10
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.针对 COVID-19 严重程度,靶向 SARS-CoV-2 表位的抗体谱存在差异。
Virulence. 2022 Dec;13(1):890-902. doi: 10.1080/21505594.2022.2073025.
一种工程化的人源单克隆抗体对 SARS 样病毒具有广泛而强大的活性。
Science. 2021 Feb 19;371(6531):823-829. doi: 10.1126/science.abf4830. Epub 2021 Jan 25.
4
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines.新冠病毒疫苗成功的影响因素:病毒遗传变异性和宿主免疫。
Biomed Pharmacother. 2021 Apr;136:111272. doi: 10.1016/j.biopha.2021.111272. Epub 2021 Jan 12.
5
Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips.核衣壳蛋白和刺突糖蛋白作为 COVID-19 快速免疫检测靶点的比较研究及免疫检测试纸条的建立。
Mol Immunol. 2021 Mar;131:6-12. doi: 10.1016/j.molimm.2021.01.005. Epub 2021 Jan 9.
6
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.在 COVID-19 和恢复期,针对 SARS-CoV-2 刺突和核衣壳蛋白快速产生持久的 B 细胞记忆。
Sci Immunol. 2020 Dec 22;5(54). doi: 10.1126/sciimmunol.abf8891.
7
Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2.新型冠状病毒肺炎的药物可开发性:基于计算机模拟发现针对严重急性呼吸综合征冠状病毒2核衣壳(N)蛋白的潜在药物化合物
Genomics Inform. 2020 Dec;18(4):e43. doi: 10.5808/GI.2020.18.4.e43. Epub 2020 Dec 9.
8
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
9
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.SARS-CoV-2 核衣壳蛋白与 RIG-I 相互作用并抑制 RIG-Mediated IFN-β 产生。
Viruses. 2020 Dec 30;13(1):47. doi: 10.3390/v13010047.
10
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.无症状和轻症 SARS-CoV-2 感染患者中和抗体和 T 细胞反应的不一致性。
Sci Immunol. 2020 Dec 23;5(54). doi: 10.1126/sciimmunol.abf3698.